Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Income Statement 2020–2023
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 55,180 | 132,640 | 133,928 | 28,881 |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -22.3M | -17.8M | -13.8M | -3.5M |
| EBITDA | -22.2M | -17.7M | -13.8M | -3.5M |
| Net Income | -22.3M | -17.6M | -13.9M | -3.6M |
| Per Share Data | ||||
| EPS (diluted) | $-1.71 | $-1.48 | $-1.37 | $-1.33 |
| Shares Outstanding (dil.) | 13M | 12M | 10M | 3M |
Gain Therapeutics Inc. Income Statement — FAQ
Gain Therapeutics Inc. (GANX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's income statement history?
The chart and table above show Gain Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.